Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/16/1995 | EP0666914A1 Novel p-selectin ligand protein |
08/16/1995 | EP0666913A1 P53 protein fragments and use thereof for detecting and monitoring diseased conditions |
08/16/1995 | EP0666911A1 Multidrug resistance gene |
08/16/1995 | EP0666906A1 Cho cells expressing human endothelin receptors |
08/16/1995 | EP0666903A1 Insulin-dependent yeast or fungi |
08/16/1995 | EP0666870A1 PROTEIN FRAGMENTS OF THE $i(PECTINATUS) BACTERIUM |
08/16/1995 | EP0666869A1 Peptides tolerizing t-cells and compositions thereof |
08/16/1995 | EP0666868A1 Vascular endothelial cell growth factor antagonists |
08/16/1995 | EP0666867A1 Reagents and methods for treating rheumatoid arthritis |
08/16/1995 | EP0666866A1 Method of isolating biomolecules by ion exchange |
08/16/1995 | EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
08/16/1995 | EP0666757A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
08/16/1995 | EP0666755A1 Inhibitiion of retrovirus infection |
08/16/1995 | EP0666754A1 Synthetic lung surfactant having antioxidant properties |
08/16/1995 | EP0666751A1 Hepatitis a virus vaccines |
08/16/1995 | EP0605410B1 Immunodiagnostic assay for rheumatoid arthritis |
08/16/1995 | EP0532525B1 New protein-polycation conjugates |
08/16/1995 | EP0527809B1 Walk-through mutagenesis |
08/16/1995 | EP0439462B1 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection |
08/16/1995 | EP0418308B1 Recombinant techniques for production of novel natriuretic and vasodilator peptides |
08/16/1995 | EP0406303B1 Assay for human immunodeficiency virus |
08/16/1995 | EP0371999B1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain |
08/16/1995 | CN1106698A Prolonged delivery of peptides |
08/15/1995 | US5442050 Isolated DNA sequences |
08/15/1995 | US5442008 Stabilized polymer film coated compounds and stabilized formulations in compressed from using same |
08/15/1995 | US5441944 Substituted cyclodextrin sulfates and their uses as growth modulating agents |
08/15/1995 | US5441937 Neurotrophic factor |
08/15/1995 | US5441935 Polypeptide for treatment of small cell lung cancer in humans |
08/15/1995 | US5441934 Dna sequences |
08/15/1995 | US5441932 Antiallergens, antiinflammatory agents |
08/15/1995 | US5441931 Human amyloid protein precursor homologue and Kunitz-type inhibitors |
08/15/1995 | US5441884 Bacillus thuringiensis transposon TN5401 |
08/15/1995 | US5441883 A3 adenosine receptor, DNA, and uses |
08/15/1995 | US5441875 Urea transporter polypeptide |
08/15/1995 | US5441870 Methods for monitoring cellular processing of β-amyloid precursor protein |
08/15/1995 | US5441868 Production of recombinant erythropoietin |
08/15/1995 | US5441867 Pre-activated proteins for labelling oligonucleotide probes |
08/15/1995 | US5441739 Reduced and controlled surface binding of biologically active molecules |
08/15/1995 | US5441736 Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof |
08/15/1995 | US5441734 Crystalline zinc interferon alpha-2 having monoclinic morphology and specified x-ray diffraction analysis |
08/15/1995 | US5441703 Having conicoidal interior contour which homogeneously widens flow of reactant gases |
08/15/1995 | CA2142411A1 Polysubstituted 3-acylamino-5-phenyl-1,4- benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |
08/15/1995 | CA2142394A1 Organic compounds |
08/15/1995 | CA1336739C Diphosphonate-derivatized macromolecules |
08/15/1995 | CA1336711C Lactam derivatives, their preparation and their use as hypotensive agents |
08/15/1995 | CA1336692C Cloning and expression of the 47-kilodalton antigen of treponema pallidum |
08/15/1995 | CA1336691C Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
08/15/1995 | CA1336679C Remedy for hematopoietic tissue diseases comprising human monocytic macrophage colony stimulating factor as active ingredient |
08/15/1995 | CA1336677C Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
08/12/1995 | CA2142137A1 Sry genomic sequences and use in tissue sexing |
08/11/1995 | CA2142173A1 Hirudin derivatives and a process for their preparation |
08/10/1995 | WO1995021380A1 Assay for screening of receptor antagonists |
08/10/1995 | WO1995021267A1 Heat-inducible n-degron module |
08/10/1995 | WO1995021263A1 Heterologous dimeric proteins produced in heterokaryons |
08/10/1995 | WO1995021261A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof |
08/10/1995 | WO1995021259A1 Adenoviral-mediated method of cell transfection |
08/10/1995 | WO1995021258A1 Fusion proteins that include antibody and nonantibody portions |
08/10/1995 | WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same |
08/10/1995 | WO1995021255A1 Compositions useful in controlling marek's disease |
08/10/1995 | WO1995021254A1 Multivariant il-3 hematopoiesis fusion protein |
08/10/1995 | WO1995021253A1 Ets1 gene: a human tumor suppressor gene |
08/10/1995 | WO1995021252A2 Wd-40-derived peptides and uses thereof |
08/10/1995 | WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions |
08/10/1995 | WO1995021250A2 Production of pharmaceutical-grade plasmid dna |
08/10/1995 | WO1995021249A1 A cassette to accumulate multiple proteins through synthesis of a self-processing polypeptide |
08/10/1995 | WO1995021248A1 Method for using tobacco mosaic virus to overproduce peptides and proteins |
08/10/1995 | WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof |
08/10/1995 | WO1995021197A1 Il-3 variant hematopoiesis fusion protein |
08/10/1995 | WO1995021195A1 Non-viral vector |
08/10/1995 | WO1995021194A1 Superactive vip antagonists |
08/10/1995 | WO1995021193A1 Nerve growth factor structural analogs and their uses |
08/10/1995 | WO1995021192A1 Malaria merozoite antigen subunit vaccine |
08/10/1995 | WO1995021191A1 Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein |
08/10/1995 | WO1995021190A1 Detection of wheat that has experienced elevated temperatures during the grain filling period |
08/10/1995 | WO1995021189A1 Hepatitis b vaccine |
08/10/1995 | WO1995021188A1 Subunits of glutamate receptors, method for producing them and their use |
08/10/1995 | WO1995021184A1 Substituted purines and oligonucleotide cross-linking |
08/10/1995 | WO1995020979A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
08/10/1995 | WO1995020977A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production |
08/10/1995 | WO1995020976A1 Co-administration of interleukin-3 mutants with colony stimulating factors |
08/10/1995 | WO1995020975A1 Tef-1 isoforms and uses thereof |
08/10/1995 | WO1995020974A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
08/10/1995 | WO1995020973A1 Peptides and compounds that bind to the il-1 receptor |
08/10/1995 | WO1995020972A1 Treatment of ovarian estrogen dependent conditions |
08/10/1995 | WO1995020872A1 Genetic engineering of mollusks |
08/10/1995 | WO1995018830A3 Inhibitors of human plasmin derived from the kunitz domains |
08/10/1995 | WO1995016709A3 Anti-mullerian hormone receptor polypeptides and antibodies thereto |
08/10/1995 | WO1995001442A3 Nucleotide and amino acid sequences of the envelope 1 gene of 51 hepatitis c virus isolates and the use of reagents derived therefrom as diagnostic reagents and vaccines |
08/10/1995 | DE4435086C1 Conjugate for inducing cellular immunity contains CD8 positive cell epitope |
08/10/1995 | DE4403666A1 Untereinheiten von Glutamatrezeptoren, Verfahren zu ihrer Herstellung und ihre Verwendung Subunits of glutamate receptors, methods for their preparation and their use |
08/10/1995 | DE4400638C1 Simple recovery of alpha-foetoprotein from embryonal tissue |
08/10/1995 | CA2182731A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
08/10/1995 | CA2182708A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof |
08/10/1995 | CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions |
08/10/1995 | CA2182618A1 Subunits of glutamate receptors, method for producing them and their use |
08/10/1995 | CA2182616A1 Non-viral vector |
08/10/1995 | CA2182501A1 Genetic engineering of mollusks |
08/10/1995 | CA2182498A1 Fusion proteins that include antibody and nonantibody portions |
08/10/1995 | CA2182484A1 Multivariant il-3 hematopoiesis fusion protein |
08/10/1995 | CA2182474A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production |